Startup tests resistance to HIV drugs

June 8, 2014 - Boston Herald

by Marie Szaniszlo

A simple, fast, affordable test developed by a Boston-based MassChallenge finalist is able to determine which drugs HIV is resistant to, saving money and lives.

Using a technology called Pan Degenerate Amplification and Adaptation, Aldatu Biosciences allows doctors to match patients with drugs the HIV won't be resistant to, based on the genetics of the virus.

"If resistance is present, switching people to effective drugs improves quality of life and saves money by reducing the risk of new infections," Aldatu CEO David Raiser said. "If resistance is not present, money is saved by not switching patients to more expensive drugs unnecessarily. There are clear economic and public health benefits to performing the test, regardless of the result." Continue reading...

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in you in box.

seventh name

Learn about the groundbreaking GRACE study of HIV+ women and how it successfully enrolled large numbers of women of color in a clinical trial.

Learn what vitamins and minerals are, and get some suggestions about what supplements HIV+ women may want to take and which ones to avoid.

Get basic information about how the immune system works, its key parts, and how HIV damages it.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>